DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Pautas C, Merabet F, Thomas X et al.
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
J Clin Oncol 2010;
28: 808-814
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.